Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID05693363

Perioperative Specimen Imaging Using High-resolution 18F-FDG-PET-CT During Thoracic Surgery: a Pilot Study

Led by University Hospital, Ghent · Updated on 2025-01-15

40

Participants Needed

1

Research Sites

82 weeks

Total Duration

On this page

Sponsors

U

University Hospital, Ghent

Lead Sponsor

X

XEOS Medical

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating the use of a high-resolution PET-CT imaging device called the AURA10 Specimen Imager during thoracic surgery for patients with suspected or confirmed lung malignancies. This pilot study aims to quickly assess surgical specimen margins and lymph node status right in the operating room, helping surgeons make immediate decisions about further surgical steps. The imaging process is estimated to take less than 10 minutes per specimen. During the surgery, the AURA10 Specimen Imager is used intraoperatively to provide detailed PET-CT images of the removed tissue. This allows for stepwise assessment after each specimen is evaluated. The study focuses on the perioperative period, where the imaging device is applied to help guide surgical decisions more efficiently. Participants will undergo thoracic surgery and have their specimens imaged using the AURA10 device during the operation. Researchers will measure perioperative success in imaging with this system. Participants must be at least 18 years old and able to comply with study procedures. Safety monitoring includes checking blood glucose levels and screening for infections or conditions that may prevent surgery. The total study involvement is centered around the surgery and immediate perioperative imaging process.

CONDITIONS

Official Title

Perioperative Specimen Imaging Using High-resolution 18F-FDG-PET-CT During Thoracic Surgery: a Pilot Study

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient is 18 years of age or older.
  • Patient with suspected or confirmed lung malignancies
  • Patient is indicated to undergo thoracic surgery.
  • Patient is estimated to be compliant for study participation by the investigator.
  • Patient has freely given his/her informed consent to participate in this study.
Not Eligible

You will not qualify if you...

  • Patient has general or local contra-indications for thoracic surgery.
  • Patient has active infection.
  • Blood glucose level over 200 mg/dL on the day of surgery.
  • Pregnancy or lactation.
  • Patient participated in other clinical studies with radiation exposure of more than 1 mSv in the past year

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University Hospital Ghent

Ghent, Belgium, 9000

Actively Recruiting

Loading map...

Research Team

L

Liesbeth Desender, prof. dr.

L

Lina Vermeir

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Similar Trials

Preoperative 3D Virtual Resection for Predicting Lung Functi...

Non-small Cell Lung Cancer

Actively Recruiting

1 location

A Pilot Study of 68Ga-FAPI-RGD PET/CT Imaging in Lung Cancer...

Lung Neoplasms

Actively Recruiting

1 location

A Phase II Study of Adebrelimab with Chemotherapy and Radiot...

Respiratory Tract Neoplasms

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial